ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,793 | +41.4% | 9,269 | +35.8% | 0.00% | – |
| Q2 2023 | $86,108 | +66.9% | 6,825 | +72.4% | 0.00% | – |
| Q1 2023 | $51,602 | -39.6% | 3,959 | -18.1% | 0.00% | – |
| Q4 2022 | $85,369 | +35.5% | 4,833 | +15.6% | 0.00% | – |
| Q3 2022 | $63,000 | +50.0% | 4,182 | +46.5% | 0.00% | – |
| Q2 2022 | $42,000 | -96.0% | 2,854 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $1,038,000 | +2156.5% | 46,128 | +1734.1% | 0.00% | – |
| Q4 2021 | $46,000 | +48.4% | 2,515 | +7.8% | 0.00% | – |
| Q3 2021 | $31,000 | -42.6% | 2,334 | -20.2% | 0.00% | – |
| Q2 2021 | $54,000 | +38.5% | 2,923 | +10.5% | 0.00% | – |
| Q1 2021 | $39,000 | +5.4% | 2,646 | 0.0% | 0.00% | – |
| Q4 2020 | $37,000 | -7.5% | 2,646 | -47.9% | 0.00% | – |
| Q3 2020 | $40,000 | +29.0% | 5,076 | +7.8% | 0.00% | – |
| Q2 2020 | $31,000 | -8.8% | 4,709 | -3.2% | 0.00% | – |
| Q1 2020 | $34,000 | – | 4,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 875,000 | $13,138,000 | 2.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 417,400 | $6,267,000 | 2.63% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 16,933,530 | $127,255,604,000 | 2.31% |
| Adirondack Research & Management Inc. | 123,148 | $1,849,000 | 2.19% |
| Smith, Graham & Co., Investment Advisors, LP | 966,216 | $14,508,000 | 1.18% |
| Lombard Odier Asset Management (Switzerland) SA | 839,521 | $12,605,000 | 0.84% |
| HENNESSY ADVISORS INC | 946,800 | $14,216,000 | 0.83% |
| Waterfront Wealth Inc. | 95,403 | $1,464,000 | 0.74% |
| Arjuna Capital | 84,697 | $1,272,000 | 0.62% |
| SummerHaven Investment Management, LLC | 62,844 | $944,000 | 0.58% |